Abhishek Shah is the Co-Founder and CEO at Wellthy Therapeutics, a leading digital therapeutics company working across Europe & Asia. Its proprietary Wellthy CARE ™ DTx platform delivers regulatory compliant, Software as a Medical Device (SaMD) based digital health solutions. Wellthy enables biopharma & medtech to deploy and scale these solutions, accelerating time to market, while minimizing risk and cost. It has a proven track record of developing and commercializing digital patient support programs, digital therapeutics, and companion SaMDs in Cardiology, Women’s Health, Diabetes, Pulmonology & Select Rare Diseases in Europe & Asia.
Other speakers in 2022
Mats Hansson
Senior Professor of Biomedical Ethics at the Centre for Research Ethics & Bioethics, Uppsala University
Coordinator and Academic Lead of the IMI-project PREFER (2016-2022)






